Cargando…
Is Exploration of Alternate Immune Pathways Needed in Hidradenitis Suppurativa? A Case of Atopic Dermatitis and Concurrent Hidradenitis Suppurativa Responding to Dupilumab
Hidradenitis suppurativa (HS) is an inflammatory dermatosis associated with overactive T helper 1/T helper 17 (Th1/Th17) cells. HS has been effectively treated with biologic medications; however, many such biologics lack large randomized controlled trials. Only one such biologic, adalimumab, has bee...
Autores principales: | McCormack, Sean, Tazudeen, Noor, Garden, Benjamin C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10615576/ https://www.ncbi.nlm.nih.gov/pubmed/37908412 http://dx.doi.org/10.1155/2023/5189034 |
Ejemplares similares
-
Successfully and safety use of dupilumab in the management of severe atopic dermatitis and concomitant moderate‐to‐severe hidradenitis suppurativa
por: Molinelli, Elisa, et al.
Publicado: (2022) -
Hidradenitis suppurativa in AIDS
por: Khambhati, Ravi, et al.
Publicado: (2010) -
Hidradenitis suppurativa and intimacy
por: Jemec, G.
Publicado: (2018) -
Coexistence of Hidradenitis Suppurativa and Steatocystoma Multiplex:
Is It a New Variant of Hidradenitis Suppurativa?
por: Fletcher, Joshua, et al.
Publicado: (2021) -
Assessing unmet needs in patients with hidradenitis suppurativa
por: Chadha, Simran A., et al.
Publicado: (2023)